Determining the physiological mechanisms behind the ObeEnd device on (1) hormones associated with weight loss and (2) recovery from exercise
In Canada, approximately 1 in 4 adults are living with obesity. Obesity is cause by a complex interplay of genetic, behavioural, and environmental factors that can increase the risk of developing non-communicable diseases such as Type 2 diabetes mellitus, coronary heart disease, asthma, several cancers, and disability in adulthood. Restricting caloric consumption and increasing physical activity levels are used in efforts to induce weight loss. However, using these methods alone may not be sufficient in sustaining long-term weight loss. The ObeEnd device manufactured by WAT Medical Enterprise, promises new and innovative wellness technology that uses electrical pulses to stimulate acupressure points to help control appetite and recovery from exercise. More research is needed to identify the physiological mechanisms of this device which will provide evidence for the company to make recommendations to optimize weight loss and help mitigate public health initiatives to reduce obesity among Canadians and associated co-morbidities.